Partial Tumor Irradiation and Immunotherapy for Unresectable Lung Cancer — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Partial Tumor Irradiation and Immunotherapy for Unresectable Lung Cancer — Stella

Home/Lung Adenocarcinoma/

View on ClinicalTrials.gov

Recruiting

Back to Lung Adenocarcinoma trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

Austria

Radiation Oncology Department, Krems, Austria

Key details

Sponsor

Karl Landsteiner University of Health Sciences

Enrollment target

~10 participants

Started

February 2026

Primary completion

February 2028

Age range

18 Years and older

Last updated February 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.